Q32 Bio Inc.

NASDAQ:QTTB

Biotechnology

Healthcare
$8.48 -1.70%

-$0.22 today

Market cap
$253.75M
Beta
-0.23
P/E (TTM)
5.4
EPS (TTM)
$2.36
52W Low $1.35High $14.85

Volume 0.31M

Average 0.74M

Income Statement

Follow revenue through to earnings.

Revenue

$53.74M

FY 2025 · Annual

Operating Income

$16.90M

FY 2025 · Annual

Net Income

$29.82M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue33.97M6.65M(6.65M)053.74M
Cost of Revenue9.54M2.6M499K487K391K
Gross Profit24.43M6.65M(6.65M)(487K)53.35M
Gross Margin71.9%100.0%100.0%—99.3%
Research & Development93.09M35.81M31.73M48.14M19.16M
Selling, General & Admin27.29M10.06M9.88M17.47M17.68M
Operating Expenses120.38M45.88M41.6M65.61M36.44M
Depreciation & Amortization9.54M370K499K487K391K
EBITDA(86.22M)(38.86M)(47.76M)(45.3M)17.29M
EBITDA Margin-253.8%-584.2%718.0%—32.2%
Operating Income(95.95M)(39.23M)(48.26M)(66.1M)16.9M
Operating Margin-282.4%-589.8%725.5%—31.5%
Interest Income185K3.23M03.9M2.2M
Interest Expense000300K1.1M
Other Income / Expenses185K(3.52M)(5.17M)18.39M12.92M
Income Before Tax(95.76M)(42.75M)(53.43M)(47.71M)29.82M
Pre-Tax Margin-281.9%-642.7%803.3%—55.5%
Income Tax Expense062K318K21K0
Net Income(95.76M)(42.81M)(53.74M)(47.73M)29.82M
Net Margin-281.9%-643.6%808.0%—55.5%
EPS (Basic)(31.18)(13.42)(16.70)(5.12)2.42
EPS (Diluted)(31.18)(13.42)(16.70)(6.58)2.42
Weighted Avg Shares3.07M3.19M3.22M12.2M12.3M
Weighted Avg Shares (Diluted)3.07M3.19M3.22M12.2M12.31M

QTTB Earnings Waterfall · TTM

NASDAQ:QTTB · Revenue to Net Income

Key Ratios

EPS$2.66
Gross Margin25.0%
Net Margin26.9%
P/E Ratio-1.0
P/S Ratio0.2

Analysis

$53.7M of revenue converted into $33.2M of net income for the selected period. Gross margin is 25.0% and net margin is 26.9%, showing how much revenue survives after costs and taxes. EPS is $2.66, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 6, 2026
SC 13G/ASC 13G/A filingNov 6, 2026
8-KCurrent reportNov 4, 2026
10-QQuarterly reportNov 4, 2026
SC 13GSC 13G filingOct 28, 2026

How much revenue does QTTB generate?

Q32 Bio Inc. (QTTB) reported $53.74M of revenue in fiscal 2025.

Is QTTB profitable?

Q32 Bio Inc. (QTTB) reported $29.82M of net income, with a net margin of 55.5%.